• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Novartis

RayzeBio Indianapolis
Manufacturing

BMS to build $173M radiopharmaceutical plant in Indiana

BMS will spend $173 million to build a second radiopharmaceutical manufacturing facility in Indiana to couple with its current site in Indianapolis.
Kevin Dunleavy Aug 27, 2026 2:45pm
Law Legal System Justice Crime concept Mallet Gavel Hammer and Scales on tabl

Sandoz inks dual settlements to resolve most US antitrust claims

Aug 3, 2026 10:18am
NVS

Novartis' Pluvicto unlocks substantial new patient pool

Aug 3, 2026 8:33am
Traffic light go start restart green light

After 3 CRLs, FDA approves Outlook's AMD drug Lytenava

Jul 27, 2026 11:51am
Narasimhan

Novartis CEO shrugs off oral PCSK9 threat amid Q2 growth

Jul 21, 2026 10:36am
Novartis brand

Novartis reconnects to its past as it moves forward

Jul 20, 2026 8:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings